This site is intended for health professionals only

Published on 7 December 2011

Share this story:

Echocardiography ‘can predict trastuzumab AEs’


Echocardiography has a central role to play in identifying patients at risk of suffering heart damage from cancer therapies, and also in evaluating potential cardio protective treatments, according to the findings of two studies presented at the “EUROECHO and other Imaging Modalities” 2011 Congress in Budapest, Hungary.

One study reported on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: